AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05555693 — intervention group
Intervention type: OTHER
Intervention: Collecting clinical data, EGG，Brain Metabolomic Characteristics(with Magnetic Resonance Spectroscopy), blood gas data and blood sample
Description: Collecting clinical data(before induction of anesthesia and first day after surgery), EGG（first day after surgery），Magnetic Resonance Spectroscopy data (before induction of anesthesia and first day after surgery)blood gas data(before induction of anesthesia and first day after surgery) and blood sample （before induction of anesthesia and first day, third day and 7th day after surgery）
Study NCT05663034 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness-based treatment for insomnia (MBTI)
Description: A 6-week intervention that uses the principles and practices of mindfulness meditation along with behavioral strategies (stimulus control, sleep restriction therapy) to reduce symptoms of insomnia
Study NCT05663034 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Description: Standard of care for adults with chronic insomnia. 6-week program that uses behavioral techniques to decrease psychophysiological arousal and increase sleep propensity to deepen and consolidate sleep.
Study NCT04921501 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HD ECG
Description: This experimental procedure is a passive, non-invasive, high-density surface ECG recording using 128 skin electrodes.The electrodes are positioned on strips of 10 electrodes to be prepared with adhesive tape and coated with conductive gel before installation on the patient. The total duration of the acquisition is 10 to 30 minutes.
Study NCT05265377 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stelo
Description: Use of Stelo exoskeleton in nine rehabilitation sessions
Study NCT04707352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: All eligible subjects will receive Dapagliflozin 10 mg each day. The study treatment will be provided for the duration of the trial from baseline (Day 1) through last visit (Day 180).
Study NCT06420128 — intervention group
Intervention type: OTHER
Intervention: Primary care team
Description: Patients whose general practitioner is a member of a primary care team since at least 12 months
Study NCT06033508 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise with whole body vibration device
Description: exercise with whole body vibration device
Study NCT06033508 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo exercise
Description: exercise without vibration on land
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Navicular Drop Test
Description: The researchers will measure the distance between the navicular tuberosity and the ground with a caliper with non-weight bearing in sitting. After that, the distance between the ground and the navicular tuberosity will be measured in standing while weight-bearing. The researchers will evaluate both sides and record the value in mm. According to Navicular Drop Test, the difference between weighted and unweighted measurements is considered normal (neutral) if it is between 5 and 9 mm, pronation (pes planus) if it is 10 mm or more, and supination (pes cavus) if it is 4 mm or less. In our study, individuals with a difference of 10 mm or more in both feet will be included in the pes planus, and individuals with a difference between 5-9 mm will be included in the control group.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Navicular Drop Test
Description: The researchers will measure the distance between the navicular tuberosity and the ground with a caliper with non-weight bearing in sitting. After that, the distance between the ground and the navicular tuberosity will be measured in standing while weight-bearing. The researchers will evaluate both sides and record the value in mm. According to Navicular Drop Test, the difference between weighted and unweighted measurements is considered normal (neutral) if it is between 5 and 9 mm, pronation (pes planus) if it is 10 mm or more, and supination (pes cavus) if it is 4 mm or less. In our study, individuals with a difference of 10 mm or more in both feet will be included in the pes planus, and individuals with a difference between 5-9 mm will be included in the control group.
Study NCT06631053 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: velocity-based FIT (VBFIT)
Description: Participants will ambulate unilaterally using a shoe modified with a 5cm rocker-style stack and forearm crutches for the duration of the study.~All participants will complete two testing sessions prior to ULLS, one testing session at day 13, and two testing sessions at the end of the study. Those assigned to the exercise group will perform a both high-intensity resistance and aerobic exercise three times per week
Study NCT06631053 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Exercise
Description: Participants will ambulate unilaterally using a shoe modified with a 5cm rocker-style stack and forearm crutches for the duration of the study.~All participants will complete two testing sessions prior to ULLS, one testing session at day 13, and two testing sessions at the end of the study.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Foot Posture Index
Description: The index consists of six items in which the foot is evaluated observationally. In the evaluation, the individual is asked to stand in a comfortable and relaxed position. The researcher observes the medial longitudinal arch structure, the structure of the talonavicular joint region, the degree of abduction/adduction in the forefoot relative to the hindfoot in the front part of the foot. In the back foot, inversion/eversion of the calcaneus, talus head position, and curvatures above and below the lateral malleolus are evaluated. The total score is reached by scoring each criterion between -2 and +2 values. 0; neutral position, (+) values; pronation (pes planus), (-) values indicate supination (pes cavus). Individuals with +6 to +12 points from this index will be included in our study.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Foot Posture Index
Description: The index consists of six items in which the foot is evaluated observationally. In the evaluation, the individual is asked to stand in a comfortable and relaxed position. The researcher observes the medial longitudinal arch structure, the structure of the talonavicular joint region, the degree of abduction/adduction in the forefoot relative to the hindfoot in the front part of the foot. In the back foot, inversion/eversion of the calcaneus, talus head position, and curvatures above and below the lateral malleolus are evaluated. The total score is reached by scoring each criterion between -2 and +2 values. 0; neutral position, (+) values; pronation (pes planus), (-) values indicate supination (pes cavus). Individuals with +6 to +12 points from this index will be included in our study.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Balance
Description: Static and dynamic balance and stability limit values of individuals will be evaluated with the HUR Smart Balance (SME Inc, USA) balance measurement device. The device consists of a computer and a platform on which individuals can place their feet. For static balance measurement, individuals will be asked to place their feet on the marked places on the platform. The researchers will evaluate the balance in four different situations, 30 seconds each. In the first test, individuals keep the balance on firm ground with their eyes open. The second test performed on the firm ground with eyes closed, in the third test, on the soft ground with eyes open, and in the fourth test, on the soft ground with eyes closed. For dynamic balance, individuals will be asked to extend their body weight to the front, back, and sides with their feet in 4 different directions for 8 seconds.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Balance
Description: Static and dynamic balance and stability limit values of individuals will be evaluated with the HUR Smart Balance (SME Inc, USA) balance measurement device. The device consists of a computer and a platform on which individuals can place their feet. For static balance measurement, individuals will be asked to place their feet on the marked places on the platform. The researchers will evaluate the balance in four different situations, 30 seconds each. In the first test, individuals keep the balance on firm ground with their eyes open. The second test performed on the firm ground with eyes closed, in the third test, on the soft ground with eyes open, and in the fourth test, on the soft ground with eyes closed. For dynamic balance, individuals will be asked to extend their body weight to the front, back, and sides with their feet in 4 different directions for 8 seconds.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Plantar Pressure Analysis
Description: Plantar pressure analysis of individuals will be evaluated by measuring with the DIERS Pedoscan DICAM 3 v3.10.8 (2019) device. DIERS Pedoscan is a system integrated into the treadmill that measures the pressure distribution on the sole during stance. As a result of this evaluation, right-left and anterior-posterior weight transfer, left-right foot rotation, lateral mobility, the center of gravity movement, and swing area data will be recorded.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Plantar Pressure Analysis
Description: Plantar pressure analysis of individuals will be evaluated by measuring with the DIERS Pedoscan DICAM 3 v3.10.8 (2019) device. DIERS Pedoscan is a system integrated into the treadmill that measures the pressure distribution on the sole during stance. As a result of this evaluation, right-left and anterior-posterior weight transfer, left-right foot rotation, lateral mobility, the center of gravity movement, and swing area data will be recorded.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Gait Analysis
Description: Gait analysis of individuals will be evaluated with the DIERS Leg Axis DICAM 3 v3.10.8 (2019) system. The system consists of a treadmill, computer, and cameras. Before the measurement, colored markers will be placed on the knee and ankle joints of the individual. For gait assessment, individuals will walk at their preferred comfortable walking speed. In the evaluation, joint angles, walking speed, step lengths are recorded. Evaluation time is approximately 5 minutes.
Study NCT05240287 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Gait Analysis
Description: Gait analysis of individuals will be evaluated with the DIERS Leg Axis DICAM 3 v3.10.8 (2019) system. The system consists of a treadmill, computer, and cameras. Before the measurement, colored markers will be placed on the knee and ankle joints of the individual. For gait assessment, individuals will walk at their preferred comfortable walking speed. In the evaluation, joint angles, walking speed, step lengths are recorded. Evaluation time is approximately 5 minutes.
Study NCT04393935 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacy Delivered PrEP Intervention
Description: Men who are eligible and agree to the clinical screener will be provided with a pre-packaged kit of self-administered tests for HIV, rectal chlamydia, syphilis and gonorrhea and creatinine and directed back to the private area of the pharmacy to perform their screenings. Participants will be asked to return the screening tests to the pharmacy technician. The pharmacy technician will process/ interpret the results of the rapid HIV test first in case a treatment referral needs to be set up. Then s/he will process/interpret the results of a rapid rectal chlamydia, syphilis, gonorrhea and rapid finger prick creatinine test. HIV negative customers will be provided with their results and be given a 30-day prescription for PrEP, culturally appropriate PrEP counseling and a follow-up appointment with a PrEP prescribing physician. Participants will be contacted after 3 months to determine whether they continued PrEP use.
Study NCT04921501 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conventional 12-lead ECG
Description: This standard 12-lead ECG is defined on the HD ECG, from electrodes F13, G3, G14, H5, H15, H25 corresponding to the precordial electrodes. 4 limb electrodes will be added for the frontal leads. Thus, the HD and 12-lead ECGs will be obtained simultaneously.
Study NCT06194201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS9432
Description: Dosing frequency: intravenously once week
Study NCT06194201 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caspofungin Acetate for Injection
Description: Dosing frequency: D1 70mg，followed by 50mg intravenously once daily
Study NCT06226415 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation therapy
Description: The study lasted 14d for each patient. During the treatment, All the participants were provided with the rehabilitation therapy, which included routine rehabilitation, cognitive training, swallowing function training and nutrition support.~Particularly, due to dysphagia, the patients enrolled might face difficulty in eating. For patients who were able to finish intake via mouth by compensatory means, the consistency, type, and size of food bolus was arranged. For those who cannot acquire sufficient nutrition through oral intake, the nasogastric tube feeding was provided.
Study NCT06226415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy
Description: The study lasted 14d for each patient. During the treatment, All the participants were provided with the rehabilitation therapy, which included routine rehabilitation, cognitive training, swallowing function training and nutrition support.~Particularly, due to dysphagia, the patients enrolled might face difficulty in eating. For patients who were able to finish intake via mouth by compensatory means, the consistency, type, and size of food bolus was arranged. For those who cannot acquire sufficient nutrition through oral intake, the nasogastric tube feeding was provided.
Study NCT06226415 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block
Description: Based on the invention above, the patients in the observation group were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06226415 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: Based on the invention above, the patients in the observation group were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06293287 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Subcutaneous enoxaparin sodium
Description: Subcutaneous enoxaparin sodium injections at a dose of 4000 Axa IU once daily
Study NCT06293287 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo (0.9% saline solution)
Study NCT04967001 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PSMA PET
Description: 68Ga-PSMA PET
Study NCT04957082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Targeted SARS-CoV-2 Communication
Description: SARS-CoV-2 video tutorial includes a one minute video based messaging adjunct meant to enact a culturally targeted framing of health information presented to African Americans.
Study NCT04957082 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General SARS-CoV-2 Communication
Description: SARS-CoV-2 video tutorial is for general consumption and does not include culturally targeted information
Study NCT06137092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Factor VIII, recombinant human with Fc fusion (rFVIII-Fc)
Description: rFVIII-Fc, IV, 50 units/kg/ single dose, cross-over
Study NCT04873193 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Leo device
Description: Children's respiratory flow and volume measurements will be continuously recorded using the Leo device during oscillometry and pneumotach procedures.
Study NCT05062707 — intervention group
Intervention type: PROCEDURE
Intervention: Blood sampling
Description: Study measurements will be performed twice and consist of blood withdrawal and physical examination (weight, height, waist-hip ratio, and blood pressure).
Study NCT06416982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perineal massage
Description: 2 minutes of perineal massage as described in arm/group descriptions.
Study NCT01092169 — intervention group
Intervention type: OTHER
Intervention: No intervention
Study NCT04909112 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of olfactory function
Description: Evaluation of olfactory function using olfactory detection thresholds
Study NCT04909112 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of taste function
Description: Evaluation of taste function using taste detection thresholds
Study NCT04909112 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of (intra-nasal and oral) trigeminal functions
Description: Evaluation of (intra-nasal and oral) trigeminal, interacting with olfactory and taste pathways, using odor and taste stimuli.
Study NCT05125809 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Setrusumab
Description: A fully human sclerostin neutralizing monoclonal antibody (mAb) administered once a month (QM) via intravenous (IV) infusion
Study NCT05125809 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Setrusumab
Description: A fully human sclerostin neutralizing monoclonal antibody (mAb) administered once a month (QM) via intravenous (IV) infusion
Study NCT06198777 — intervention group
Intervention type: DEVICE
Intervention: Magnetometer
Description: Inspection equipment for magnetocardiography
Study NCT05012436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YHD1119 75mg
Description: A single oral dose
Study NCT04805827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: 1 tablet contains 600 mg Gabapentin
Study NCT04805827 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neurontin
Description: 2 capsule contains 2\*300 = 600 mg Gabapentin
Study NCT06222333 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Respiratory physiotherapy
Description: In this group of patients, in addition to routine analgesic treatment, triflow use and deep breathing training would be given by the physiotherapist. Patients in this group will do breathing exercises 8 hours a day, 10 times an hour.
Study NCT05125809 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A 5% dextrose/glucose solution administered QM via IV infusion
Study NCT06222333 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conservative Treatment
Description: Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen.
Study NCT05464784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MN-001
Description: MN-001 is a novel, orally bioavailable small molecule compound
Study NCT05464784 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: MN-001 placebo
Description: The placebo tablet is identical in appearance to the MN-001 tablet, and contains excipients of MN-001.
Study NCT06379893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voltaren Gel 1% (diclofenac sodium) (US only)
Description: Participants in the US will use Volatren Gel containing 1% diclofenac sodium.
Study NCT06379893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voltaren Gel 1.16% (diclofenac diethylammonium) (EU only)
Description: Participants in the EU will use Volatren Gel containing 1.16% diclofenac diethylammonium.
Study NCT06379893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voltaren Gel 2.32% (diclofenac diethylammonium) (EU only)
Description: Participants in the EU will use Volatren Gel containing 2.32% diclofenac diethylammonium.
Study NCT06391034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hyperpolarized pyruvate +/-urea (13C/15N)
Description: Given IV
Study NCT06391034 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Non-investigational Stereotactic body radiotherapy (SBRT)
Description: Stereotactic body radiotherapy given outside of this study
Study NCT06391034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Description: Radiation therapy given outside of this study
Study NCT06391034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multi-parametric magnetic resonance imaging (mpMRI)
Description: Imaging scan
Study NCT06391034 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Non-interventional hormone therapy
Description: Therapy given outside of this study as part of standard of care
Study NCT06391034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prostate Biopsy
Description: Biopsies may be taken from Trans-rectal ultrasound (TRUS) -visible lesion at the urologist's discretion